Harbour Investments’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.89K | Sell |
89
-3
| -3% | -$165 | ﹤0.01% | 2887 |
|
|
2025
Q1 | $6.5K | Sell |
92
-3
| -3% | -$212 | ﹤0.01% | 2719 |
|
|
2024
Q4 | $6.24K | Sell |
95
-11
| -10% | -$723 | ﹤0.01% | 2649 |
|
|
2024
Q3 | $7.45K | Buy |
106
+6
| +6% | +$422 | ﹤0.01% | 2481 |
|
|
2024
Q2 | $8.23K | Sell |
100
-155
| -61% | -$12.8K | ﹤0.01% | 2339 |
|
|
2024
Q1 | $22.3K | Buy |
255
+11
| +5% | +$961 | ﹤0.01% | 1907 |
|
|
2023
Q4 | $23.5K | Buy |
244
+128
| +110% | +$12.3K | ﹤0.01% | 1799 |
|
|
2023
Q3 | $10.3K | Buy |
116
+22
| +23% | +$1.95K | ﹤0.01% | 2025 |
|
|
2023
Q2 | $8.15K | Buy |
94
+1
| +1% | +$87 | ﹤0.01% | 2130 |
|
|
2023
Q1 | $9.04K | Buy |
93
+29
| +45% | +$2.82K | ﹤0.01% | 2047 |
|
|
2022
Q4 | $6.62K | Sell |
64
-13
| -17% | -$1.35K | ﹤0.01% | 2124 |
|
|
2022
Q3 | $6K | Hold |
77
| – | – | ﹤0.01% | 2095 |
|
|
2022
Q2 | $6K | Buy |
+77
| New | +$6K | ﹤0.01% | 2095 |
|
|
2021
Q4 | $11K | Sell |
123
-1,451
| -92% | -$130K | ﹤0.01% | 1875 |
|
|
2021
Q3 | $122K | Buy |
1,574
+124
| +9% | +$9.61K | ﹤0.01% | 1265 |
|
|
2021
Q2 | $121K | Sell |
1,450
-4
| -0.3% | -$334 | ﹤0.01% | 1297 |
|
|
2021
Q1 | $110K | Buy |
+1,454
| New | +$110K | ﹤0.01% | 1253 |
|